Post-Authorization Active Surveillance Safety Study Using Secondary Data to Monitor Real-World Safety of Spikevax in Europe (COVID-19)

25/11/2021
18/09/2026
EU PAS number:
EUPAS44273
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information